Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) Accounts Payable: ¥167.9 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688212 Shanghai Aohua Photoelectricity Endoscope Co Ltd SHSE:688212
71 GF Score
Price ¥32.37
GF Value ¥62.27
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shanghai Aohua Photoelectricity Endoscope Co Accounts Payable?

Shanghai Aohua Photoelectricity Endoscope Co SHSE:688212 +3.92% 71 Accounts Payable is ¥167.9 Mil as of Mar. 2026. GuruFocus rates SHSE:688212 with a GF Score™ of 71/100 and a GF Value™ of ¥62.27 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Shanghai Aohua Photoelectricity Endoscope Co's Accounts Payable for the quarter that ended in Mar. 2026 was ¥167.9 Mil.

Shanghai Aohua Photoelectricity Endoscope Co's quarterly Accounts Payable increased from Sep. 2025 (¥106.7 Mil) to Dec. 2025 (¥164.8 Mil) and increased from Dec. 2025 (¥164.8 Mil) to Mar. 2026 (¥167.9 Mil).

Shanghai Aohua Photoelectricity Endoscope Co's annual Accounts Payable increased from Dec. 2023 (¥56.1 Mil) to Dec. 2024 (¥82.1 Mil) and increased from Dec. 2024 (¥82.1 Mil) to Dec. 2025 (¥164.8 Mil).

Shanghai Aohua Photoelectricity Endoscope Co Accounts Payable Related Terms

Shanghai Aohua Photoelectricity Endoscope Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for Shanghai Aohua Photoelectricity Endoscope Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Aohua Photoelectricity Endoscope Co Accounts Payable Chart

Shanghai Aohua Photoelectricity Endoscope Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only 15.39 49.97 56.14 82.13 164.83

Shanghai Aohua Photoelectricity Endoscope Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.61 92.44 106.67 164.83 167.92
SHSE:688212
71GF Score
Shanghai Aohua Photoelectricity Endoscope Co Ltd SHSE:688212
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Aohua Photoelectricity Endoscope Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ¥167.9 Mil mean?
Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) has a Accounts Payable of ¥167.9 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Shanghai Aohua Photoelectricity Endoscope Co and its competitors.
Is Shanghai Aohua Photoelectricity Endoscope Co's Accounts Payable too high?
Shanghai Aohua Photoelectricity Endoscope Co's current Accounts Payable is ¥167.9 Mil. Overall, Shanghai Aohua Photoelectricity Endoscope Co has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Aohua Photoelectricity Endoscope Co's Accounts Payable compare to ABT and SYK?
Shanghai Aohua Photoelectricity Endoscope Co's Accounts Payable of ¥167.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Shanghai Aohua Photoelectricity Endoscope Co and its competitors. Shanghai Aohua Photoelectricity Endoscope Co's current Accounts Payable is ¥167.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Aohua Photoelectricity Endoscope Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥62.27, compared to a current price of ¥32.37 — trading 48% below its estimated fair value. The current Accounts Payable is ¥167.9 Mil. Shanghai Aohua Photoelectricity Endoscope Co's overall GF Score™ is 71/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212), the current Accounts Payable is ¥167.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Aohua Photoelectricity Endoscope Co (SHSE:688212) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Aohua Photoelectricity Endoscope Co stock appears to be undervalued. The current stock price of ¥32.37 is trading 48% below its estimated GF Value™ of ¥62.27. GuruFocus considers Shanghai Aohua Photoelectricity Endoscope Co to be Significantly Undervalued.

Key valuation signals for SHSE:688212:

  • Accounts Payable: ¥167.9 Mil
  • GF Value™: ¥62.27 vs. price of ¥32.37 (48% below fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Aohua Photoelectricity Endoscope Co Business Description

Address No. 66, Lane 133, Guangzhong Road, Minhang District, Shanghai, CHN, 201108
Shanghai Aohua Photoelectricity Endoscope Co Ltd is engaged in the research and development, production and sales of electronic endoscope equipment and endoscope diagnostic and surgical consumables.
71GF Score

Get the complete analysis for SHSE:688212

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥32.37
Price
¥62.27
GF Value